Acthar Gel was approved by the FDA for treatment of some autoimmune diseases including lupus in 1952. Below are answers to some questions you may have about this drug as you explore it as an option to ...
DUBLIN, July 1, 2021 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced new treatment guidelines for sarcoidosis from the European Respiratory ...
Credit: Mallinckrodt. Acthar Gel single-dose prefilled SelfJect Injector is supplied as 40 USP Units/0.5mL and 80 USP Units/mL dosage strengths. The new injector device is intended to simplify the ...
– Electronic medical chart analysis showed Acthar Gel was associated with clinical improvements and a reduction in prescriptions for concomitant medications in refractory rheumatoid arthritis patients ...
– Survey findings showed a majority of participants had a favorable experience injecting Acthar Gel via SelfJect, with a high level of satisfaction, confidence, convenience, and ease of use regarding ...
– Retrospective analysis suggests Acthar Gel treatment was associated with similar improvement in health status and overall symptom reduction in African Americans and non-African Americans with ...
-- Findings from two health economics analyses of Acthar Gel provide further insight into its cost-effectiveness as a treatment option for advanced symptomatic sarcoidosis, 1 and its impact on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results